People · Operator
Named in public records as an officer, director or promoter · active 2008–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amplimed Corp | — | Biotechnology | Series A | $29.0M | $258.2M | 2008 |
Joel Smolen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joel Smolen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harry A. George | 1 | 3 |
| John M. Holliman | 1 | 3 |
| Ronald M. Garren | 1 | 1 |
| Joel A. Smolen | 1 | 1 |
| Chris Richied | 1 | 1 |
| Steve T. Steinman | 1 | 1 |
| Randolph T. Steer | 1 | 1 |
| Ronald Garren | 1 | 1 |
| Randolph Steer | 1 | 1 |
| Steve Steinman | 1 | 1 |
| William Remers | 1 | 1 |
| William T. Remers | 1 | 1 |
| William Reemers | 1 | 1 |
| Robert T. Dorr | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.